Luo, Zhen
Tu, Hong
Zhang, Xiang
Wang, Xiao
Ouyang, Wen
Wei, Xinchuan
Zou, Xiaohua
Zhu, Zhaoqiong
Li, Yalan
Shangguan, Wangning
Wu, Hui
Wang, Yaping
Guo, Qulian
Clinical trials referenced in this document:
Documents that mention this clinical trial
Efficacy and Safety of HSK3486 for Anesthesia/Sedation in Patients Undergoing Fiberoptic Bronchoscopy: A Multicenter, Double-Blind, Propofol-Controlled, Randomized, Phase 3 Study
https://doi.org/10.1007/s40263-021-00890-1
Funding for this research was provided by:
Haisco Pharmaceutical Group Co., Ltd.
Article History
Accepted: 12 December 2021
First Online: 14 February 2022
Declarations
:
: The study received funding from Haisco Pharmaceutical Group Co., Ltd. The open access fee was also paid by Haisco Pharmaceutical Group Co., Ltd. The sponsor was not involved in any of the study design; data collection, analysis and interpretation; manuscript writing and submission.
: ZL, HT, XZ, XW, WOY, XCW, XHZ, ZQZ, YLL, WNSG, HW, YPW and QLG declare that they have no conflict of interest.
: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
: Not applicable.
: The study was approved by the ethics committee of each participating hospital.
: Informed consent was obtained from all individual participants included in the study.
: Not applicable.
: Conceptualization: ZL and XW; Validation: ZL, HT, XZ, XW, WOY, XCW, XHZ, ZQZ, YLL, WNSG, HW, YPW and QLG; Formal analysis: ZL, HT and XZ; Investigation: ZL, HT, XZ, XW, WOY, XCW, XHZ, ZQZ, YLL, WNSG, HW, YPW and QLG; Data curation: ZL, HT, XZ, XW, WOY, XCW, XHZ, ZQZ, YLL, WNSG, HW, YPW and QLG; Writing—original draft: ZL and HT; Writing—review and editing: XZ, XW, WOY, XCW, XHZ, ZQZ, YLL, WNSG, HW, YPW and QLG; Supervision: XW.